Recognizing the potential for copper-related toxicities from liposomal daunorubicin--cytarabine

Triesel K Chiang T Seabury R , et al. Recurrent and reversible bilateral palmar blue discoloration following administration of liposomal daunorubicin-cytarabine (Vyxeos®) for acute myeloid leukemia with myelodysplasia-related changes. J Oncol Pharm Pract. Epub ahead of print December 2020. DOI: 10.1177/1078155220978452.

Nagore E Insa A Sanmartín O. Antineoplastic therapy-induced palmar plantar erythrodysesthesia (‘hand-foot’) syndrome. Am J Clin Dermatol 2000; 1: 225–234.

Rosenbeck L Kiel PJ. Palmar–plantar rash with cytarabine therapy. N Engl J Med 2011; 364: e5.

Grunwald MR McDonnell MH Induru R , et al. Cutaneous manifestations in leukemia patients. Semin Oncol 2016; 43: 359–365.

Venkatesh P Kasi A. Anthracyclines. In: StatPearls. StatPearls Publishing, 2020, www.ncbi.nlm.nih.gov/books/NBK538187/ (accessed 31 December 2020).

Mitoxantrone [package insert]. Lake Forest, IL: Hospira Inc., 2018, http://labeling.pfizer.com/ShowLabeling.aspx?id=4536 (accessed 31 December 2020).

Dicko A Kwak S Frazier AA , et al. Biophysical characterization of a liposomal formulation of cytarabine and daunorubicin. Int J Pharm 2010; 391: 248–259.

Vyxeos [package insert]. Palo Alto, CA: Jazz Pharmaceuticals, Inc., 2019, https://. pp.jazzpharma.com/pi/vyxeos.en.USPI.pdf (accessed 31 December 2020).

Institute of Medicine (US) Panel on Micronutrients. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academies Press (US), 2001, p.7.

Peterson J Shook BA Wells MJ , et al. Cupric keratosis: green seborrheic keratoses secondary to external copper exposure. Cutis 2006; 77: 39–41.

Ghosh SK Rudra O Kar R , et al. A curious case of blue-green discoloration in a middle-aged indian man: chromhidrosis. Dermatol Online J 2015; 21.

Ghosh SK Bandyopadhyay D. The color of skin: green diseases of the skin, nails, and mucosa. Clin Dermatol 2019; 37: 516–519.

Royer A Sharman T. Copper toxicity. In: StatPearls. StatPearls Publishing, 2020, www.ncbi.nlm.nih.gov/books/NBK557456/ (accessed 22 January 2021).

Schilsky ML. Wilson disease: diagnosis, treatment, and follow-up. Clin Liver Dis 2017; 21: 755–767.

Collins JF Prohaska JR Knutson MD. Metabolic crossroads of iron and copper. Nutr Rev 2010; 68: 133–147.

Arredondo M Núñez MT. Iron and copper metabolism. Mol Aspects Med 2005; 26: 313–327.

Ono Y Ishigami M Hayashi K , et al. Copper accumulates in hemosiderins in livers of patients with iron overload syndromes. J Clin Transl Hepatol 2015; 3: 85–92.